Hypomania in a schizophrenic patient treated with modafinil for clozapine-induced sedation;Bir şiizofreni hastasında klozapin tedavisine modafinil eklenmesi ile ortaya çıkan hipomani

Noropsikiyatri Arsivi

Volumn 47, Issue 2, 2010, Pages 171-173

  Özer, Suzan ^a   Demir, Başaran ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Clozapine; Manic state; Modafinil; Schizophrenia

Indexed keywords

CLOZAPINE; MODAFINIL;

ADULT; ARTICLE; CASE REPORT; DAYTIME SOMNOLENCE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE EXACERBATION; HUMAN; HYPOMANIA; IRRITABILITY; MOTOR ACTIVITY; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SPEECH DISORDER;

EID: 77956259192     PISSN: 13000667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Valentino RM, Foldvary Schafer N. Modafinil in the treatment of excessive daytime sleepiness. Cleve Clin J Med 2007; 74:561-6. [Abstract]/[PDF]
2. Minzenberg MJ, Carter CS. Modafinil. A Review of Neurochemical Actions and Effects on Cognition. Neuropsychopharmacology 2008; 33:1477-502. [Abstract]/[Full Text]/[PDF]
3. Didato G, Nobili L. Treatment of narcolepsy. Expert Rev Neurother 2009; 9:897-10. [Abstract]/[Full Text]/[PDF]
4. Wisor JP, Nishino S, Sora I et al. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001; 21:1787-94. [Abstract]/[Full Text] / [PDF]
5. Yu BP, Maguire GA, Liffick TF. Modafinil for treatment of the negative symptoms of schizophrenia and antipsychotic induced sedation. Sleep 2002; 25: p. 503 (Poster özeti).
6. Teitelman E. Off-label uses of modafinil (letter). Am J Psychiatry 2001; 158:1341. [Abstract]/[Full Text]/[PDF]
7. Saavedra-Velez C, Yusim A, Anbarasan D et al. Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review. J Clin Psychiatry 2009; 70:104-12. [Abstract]
8. Frye MA, Grunze H, Suppes T et al. A Placebo-Controlled Evaluation of Adjunctive Modafinil in the Treatment of Bipolar Depression. Am J Psychiatry 2007; 164:1242-9. [Abstract]/[Full Text]/[PDF]
9. Young CR, Bowers MB, Mazure CM. Management of the adverse effects of clozapine. Schizophr Bull 1998; 24:381-90. [Abstract]/[PDF]
10. Safferman AZ, Lieberman JA, Kane JM et al. Update on the clinical efficacy and side effects of clozapine. Schizophrenia Bull 1991; 17:247-61. [Abstract]/[PDF]
11. Wolf J, Fiedler U, Anghelescu I et al. Manic switch in a patient with treatment-resistant bipolar depression treated with modafinil. J Clin Psychiatry 2006; 67:1817. [Abstract]
12. Ginsberg DL. Modafinil-Associated Mania. Primary Psychiatry 2007; 14:23-5. [Full Text]
13. Fountoulakis KN, Siamouli M, Panagiotidis P et al. Ultra short manic-like episodes after antidepressant augmentation with modafinil. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:891-2. [Abstract]/[PDF]
14. Nasr S, Wendt B, Steiner K. Absence of mood switch with and tolerance to modafinil:A replication study from a large private practice. J Affect Disord 2006; 95:111-4. [Abstract]/[Full Text]/[PDF]
15. Vorspan F, Warot D, Consoli A et al. Mania in a Boy Treated With Modafinil for Narcolepsy. Am J Psychiatry 2005; 162:813-4. [Full Text] / [PDF]
16. Berk M, Ng F, Wang WV et al. The empirical redefinition of the psychometric criteria for remission in bipolar disorder. J Affect Disord 2008; 106:153-8. [Abstract]/[Full Text]/[PDF]
17. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14:540-5. [Abstract]
18. Aǧargun MY, Çilli AS, Kara H ve ark. Epworth Uykululuk Ölçeǧinin Geçerliǧi ve Güvenilirliǧi Türk Psikiyatri Derg. 1999; 10:261-7. [Abstract]
19. Narendran R, Young CM, Valenti AM et al. Is psychosis exacerbated by modafini? Arch Gen Psychiatry 2002; 59:292-3. [Abstract]/[Full Text] /[PDF]
20. Rosenthal MH, Bryant SL. Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia. Clin Neuropharmacol 2004; 27:38-43. [Abstract]
21. Tanda G, Frau R, Di Chiara G. Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex. Psychopharmacology (Berl) 1996; 127:83-7. [Abstract]/[PDF]